Global Neurostimulation Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Neurostimulation Devices Market is presumed to reach the market size of nearly USD 26.1 Billion by 2032 from USD 10.12 Billion in 2023 with a CAGR of 11.1% under the study period 2024-2032.

Neurostimulation is a process that can be defined as the alteration of neural activity for therapies using implanted medical devices. Various devices are used for neurostimulation known as neurostimulation devices or neurostimulators. They are very helpful in the treatment of neurological diseases. They are widely used for the treatment of Perkinson's disease, various chronic disorders and epilepsy, and even for depression. Different movement disorders also use neurostimulation devices for treatment in patients.

MARKET DYNAMICS

The major boost for the market is in the form of increasing the geriatric population and the rising investment behind the development of advanced techniques and therapies for the treatment of chronic problems. Chronic diseases mostly do not have any definite treatment and this technology is helping to close that gap. The COVID-19 outbreak has also caused a growth in the market as there has been an increase in co-morbid diseases like epilepsy and migraine that can be effectively treated using neurostimulator devices. The increasing number of neurological diseases is boosting the growth of the neurostimulator devices market. The only major challenge faced by the market is the high cost of production of such devices and most of the hospitals are not advanced enough to incorporate such advanced techniques in their operational procedures. This is the only restraint being faced by the market for neurostimulator devices.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Neurostimulation Devices. The growth and trends of Neurostimulation Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Neurostimulation Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Spinal Cord Stimulators
Deep Brain Stimulators
Cochlear Implants
Vagus Nerve Stimulators
Sacral Nerve Stimulators
Percutaneous Tibial Nerve Stimulators
Transcranial Magnetic Stimulators

By Application

Chronic Pain
Movement Disorders
Hearing Impairment
Epilepsy
Urinary Incontinence
Others

By End-user

Hospitals
Ambulatory Surgery Centers
Specialty Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Neurostimulation Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Neurostimulation Devices market include Boston Scientific Corporation, Medtronic Plc, Abbott Laboratories, Nevro Corp., LivaNova Plc, Axonics Modulation Technologies Inc., Neuropace Inc., EndoStim Inc., NDI Medical, Cochlear Limited, Neuronetics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11212641

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NEUROSTIMULATION DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NEUROSTIMULATION DEVICES MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data
5.3. Analysis By Product Type
5.4. Spinal Cord Stimulators Historic and Forecast Sales By Regions
5.5. Deep Brain Stimulators Historic and Forecast Sales By Regions
5.6. Cochlear Implants Historic and Forecast Sales By Regions
5.7. Vagus Nerve Stimulators Historic and Forecast Sales By Regions
5.8. Sacral Nerve Stimulators Historic and Forecast Sales By Regions
5.9. Percutaneous Tibial Nerve Stimulators Historic and Forecast Sales By Regions
5.10. Transcranial Magnetic Stimulators Historic and Forecast Sales By Regions

6. GLOBAL NEUROSTIMULATION DEVICES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Chronic Pain Historic and Forecast Sales By Regions
6.5. Movement Disorders Historic and Forecast Sales By Regions
6.6. Hearing Impairment Historic and Forecast Sales By Regions
6.7. Epilepsy Historic and Forecast Sales By Regions
6.8. Urinary Incontinence Historic and Forecast Sales By Regions
6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL NEUROSTIMULATION DEVICES MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data
7.3. Analysis By End-user
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Ambulatory Surgery Centers Historic and Forecast Sales By Regions
7.6. Specialty Clinics Historic and Forecast Sales By Regions

8. GLOBAL NEUROSTIMULATION DEVICES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE NEUROSTIMULATION DEVICES COMPANIES

9.1. Neurostimulation Devices Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF NEUROSTIMULATION DEVICES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Medtronic Plc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Abbott Laboratories
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Nevro Corp.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. LivaNova Plc
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Axonics Modulation Technologies Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Neuropace Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. EndoStim Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. NDI Medical
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Cochlear Limited
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Neuronetics Inc
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies